[In vitro clonal assay as a predictive test of sensitivity to cytostatics in carcinoma of the human bladder].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002945:Cisplatin / Q000627:therapeutic use; D003114:Colony-Forming Units Assay; D004317:Doxorubicin / Q000627:therapeutic use; D004351:Drug Resistance; D006801:Humans; D016685:Mitomycin; D008937:Mitomycins / Q000627:therapeutic use; D013852:Thiotepa / Q000627:therapeutic use; D014410:Tumor Stem Cell Assay; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D008937:Mitomycins; D016685:Mitomycin; D004317:Doxorubicin; D013852:Thiotepa; D002945:Cisplatin
El ensayo clonal "in vitro" como prueba predictiva de sensibilidad a citostáticos en el carcinoma de vejiga humano.